MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Late-onset neurologic Wilson’s disease: case series

    I. Minaev, E. Nuzhnyi, V. Poleschuk, A. Protopopova, N. Abramycheva, S. Illarioshkin (Moscow, Russian Federation)

    Objective: To report the case series of patients with late-onset Wilson’s disease (WD) with predominantly neurological manifestation. Background: WD is a rare and treatable disorder…
  • 2024 International Congress

    Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters

    P. Vvsrk, S. Kola, R. Alugolu, R. Kandadani, R. Borgohain (Hyderabad, India)

    Objective: Idiopathic Parkinson's disease (PD) and Normal pressure hydrocephalus (NPH) can have similar clinical presentation. However, diagnostic precision is important as clinical management differs. Previous…
  • 2024 International Congress

    PD Young Ambassadors: A Peer-led, Community-Based Intervention to Raise PD Awareness in the Hispanic Communities of Chicago.

    J. Deliz, E. Espinoza, S. Kola, E. Zivin, K. Williams, J. Adrissi, P. Gonzalez-Latapi, D. Larson (Chicago, USA)

    Objective: To employ a community-based participatory research (CBPR) approach in developing and testing a workshop-based, peer-led intervention aimed at increasing PD awareness among youth and…
  • 2024 International Congress

    Clinical and neuroimaging factors associated with survival in Multiple System Atrophy

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and neuroimaging factors associated with survival in a cohort of patients with a final clinical diagnosis of Multiple System Atrophy (MSA)…
  • 2024 International Congress

    Optical Coherence Tomography Findings in Multiple System Atrophy: Insights into Disease Subtypes, Clinical Correlations, and Dopaminergic Degeneration

    Y. Kang (Hangzhou, China)

    Objective: This study aimed to evaluate optical coherence tomography (OCT) findings in multiple system atrophy (MSA) patients, with a focus on disease subtypes, clinical correlations,…
  • 2024 International Congress

    Rapid Cognitive Deterioration and Related Factors in Progressive Supranuclear Palsy: a One-Year Follow-up Study

    XY. Li, G. Tang, FT. Liu, J. Wang (Shanghai, China)

    Objective: Based on a relatively large cohort, we aimed to show the switch of cognitive status in patients with progressive supranuclear palsy (PSP) after one-year follow-up…
  • 2024 International Congress

    Cholinergic denervation is more severe in patients with Parkinson disease compared to Progressive Supranuclear Palsy-Parkinsonism subtype: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, T. Brown, S. Roytman, K. Frey, P. Scott, R. Koeppe, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: : To investigate cholinergic brain regional differences between Progressive supranuclear palsy with parkinsonism (PSP-P) and Parkinson's disease (PD), using the highly selective radiotracer for…
  • 2024 International Congress

    Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy

    A. Blazek, C. Hogen, J. Whitwell, K. Josephs, K. Kaufman, F. Ali (Rochester, USA)

    Objective: To evaluate the validity and precision of using inertial measurement units (IMU) for measurement of kinematics and spatial-temporal features of gait in progressive supranuclear…
  • 2024 International Congress

    Salivary and Plasma Heme Oxygenase-1 Concentration as a New Potential Biomarker in Parkinson Disease

    R. Yadav (Kathmandu, Nepal)

    Objective: The objective was to assess the utility of plasma and salivary heme oxygenase-1 (HO-1) concentration as a new potential biomarker for the diagnosis of…
  • 2024 International Congress

    Visual Hallucinations and α-Synuclein Oligomers in Dementia with Lewy Bodies (DLB)

    L. Franke, H. Sekiya, T. Ferman, P. Mclean, D. Dickson (Jacksonville, USA)

    Objective: To determine whether visual hallucinations (VH) in dementia with Lewy bodies (DLB) are associated with α-synuclein oligomers. Background: It is not known whether VH…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley